United States · Series A startup

Who invested in i2o Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$46Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $46MAug 2023
Investors
1
See who backed them

The rounds

  1. Aug 2023
    Series A$46M

    Source recordedSEC filing: $3.5M sold, first sale Sept 2023

Founders and team

From the SEC filings it signed: 1 on the team.

  • Kurt GravesChief Executive Officeri

On the board, as filediAnthony AiudiChristopher Gagliardi

Everyone who backed them

SanofiInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about i2o Therapeutics

Who invested in i2o Therapeutics?

i2o Therapeutics's investors include Sanofi.

How much has i2o Therapeutics raised?

i2o Therapeutics has raised $46M across 1 round since 2023.

When did i2o Therapeutics last raise?

i2o Therapeutics's most recent round was a Series A of $46M in Aug 2023.

What was i2o Therapeutics's biggest round?

Its most recent round, $46M in Aug 2023, is also its largest on record.

Who backed i2o Therapeutics first?

i2o Therapeutics's first round on record, in Aug 2023, was backed by Sanofi.

What stage is i2o Therapeutics at?

i2o Therapeutics's latest named round is a Series A, in Aug 2023.

Where is i2o Therapeutics based?

i2o Therapeutics is based in the United States.

Companies like i2o Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.